SB 6 — Controlled substances: xylazine.
Congress · introduced 2024-12-02
Latest action: — Assembly
Sponsors
- Ashby, Angelique V. (D, CA-8) — sponsor
Action timeline
- · 126 — Introduced. Read first time. To Com. on RLS. for assignment. To print.
- · 4 — From printer. May be acted upon on or after January 2.
- · 5 — Referred to Com. on PUB. S.
- · 124 — Set for hearing March 25.
- · 21 — From committee: Do pass and re-refer to Com. on APPR. (Ayes 6. Noes 0. Page 532.) (March 25). Re-referred to Com. on APPR.
- · 124 — Set for hearing April 7.
- · 343 — April 7 hearing: Placed on APPR. suspense file.
- · 124 — Set for hearing May 23.
- · 32 — Read second time. Ordered to third reading.
- · 45 — Read third time. Passed. (Ayes 38. Noes 0. Page 1472.) Ordered to the Assembly.
- · 56 — In Assembly. Read first time. Held at Desk.
- · 5 — Referred to Com. on PUB. S.
- · 21 — From committee: Do pass and re-refer to Com. on APPR. (Ayes 9. Noes 0.) (July 1). Re-referred to Com. on APPR.
- · 969 — July 16 set for first hearing. Placed on APPR. suspense file.
- · 149 — August 29 hearing: Held in committee and under submission.
Text versions
No text versions on file yet — same ingest as the action timeline populates these. Each version has direct links to the XML / HTML / PDF at govinfo.gov.
Who matters
Members ranked by combined influence on this bill: role (sponsor 5 / cosponsor 1), capped speech count from the Congressional Record, and recorded-vote engagement.
| # | Member | Role | Speeches | Voted | Score |
|---|---|---|---|---|---|
| 1 | Ashby, Angelique V. (D, state_upper CA-8) | sponsor | 0 | — | 5 |
Predicted vote
Aggregated from: actual roll-call votes (when present) → sponsor → cosponsor → party median (predicts YES when ≥25% of the caucus sponsored/cosponsored). Each row labels its confidence tier so you can see why a position was predicted.
0 predicted yes (0%) · 543 predicted no (100%) · 0 unknown (0%)
By party: · R: 0 yes / 277 no · D: 0 yes / 263 no · I: 0 yes / 3 no